These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2512138)

  • 1. Decontaminating efficacy of ciprofloxacin in an animal model.
    van Ogtrop ML; Mattie H; Guiot HF; van Furth R
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):901-3. PubMed ID: 2512138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the oropharyngeal and gastrointestinal microflora by ciprofloxacin: microbiological and clinical consequences.
    Edlund C; Nord CE
    Scand J Infect Dis Suppl; 1989; 60():98-103. PubMed ID: 2667112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance.
    van de Leur JJ; Vollaard EJ; Janssen AJ; Dofferhoff AS
    Scand J Infect Dis; 1997; 29(3):297-300. PubMed ID: 9255893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
    Patrick CC
    Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gastrointestinal epithelium and its autochthonous bacterial flora.
    Savage DC; Dubos R; Schaedler RW
    J Exp Med; 1968 Jan; 127(1):67-76. PubMed ID: 4169441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imipenem, cefotaxime and cotrimoxazole on aerobic microbial colonization of the digestive tract.
    Van der Leur JJ; Thunnissen PL; Clasener HA; Muller NF; Dofferhoff AS
    Scand J Infect Dis; 1993; 25(4):473-8. PubMed ID: 8248747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    J Infect Dis; 1985 Jul; 152(1):104-7. PubMed ID: 3159811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose ciprofloxacin for selective decontamination of the digestive tract in human volunteers.
    Meijer-Severs GJ; van Santen E; de Vries-Hospers HG
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):285-7. PubMed ID: 2351146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
    Gilbert DN; Tice AD; Marsh PK; Craven PC; Preheim LC
    Am J Med; 1987 Apr; 82(4A):254-8. PubMed ID: 3555044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.
    Karp JE; Dick JD; Merz WG
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S5-13. PubMed ID: 3127219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bacterial infection in the transplant recipient. The role of selective bowel decontamination.
    Arnow PM
    Infect Dis Clin North Am; 1995 Dec; 9(4):849-62. PubMed ID: 8747769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study.
    Heimdahl A; Gahrton G; Groth CG; Lundgren G; Lönnquist B; Ringden O; Nord CE
    Scand J Infect Dis; 1984; 16(1):51-60. PubMed ID: 6364328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages.
    Terg R; Llano K; Cobas SM; Brotto C; Barrios A; Levi D; Wasen W; Bartellini MA
    J Hepatol; 1998 Sep; 29(3):437-42. PubMed ID: 9764991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective flora suppression on colonization, infection, and mortality in critically ill patients: a one-year, prospective consecutive study.
    Hartenauer U; Thülig B; Diemer W; Lawin P; Fegeler W; Kehrel R; Ritzerfeld W
    Crit Care Med; 1991 Apr; 19(4):463-73. PubMed ID: 2019131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspects of the interaction of sporogenic aerobic bacteria with a macroorganism].
    Smirnov VV; Reznik SR
    Mikrobiol Zh (1978); 1980; 42(1):3-10. PubMed ID: 7366482
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin.
    Andremont A; Tancrede C
    Ann Microbiol (Paris); 1981; 132 B(3):419-27. PubMed ID: 7036825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of quinolones on throat- and faecal flora of healthy volunteers.
    de Vries-Hospers HG; Welling GW; van der Waaij D
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S41-4. PubMed ID: 3438150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.